Anaplastic Oligodendroglioma (AO) Active Not Recruiting Phase 1 Trials for Lapatinib (DB01259)
Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant
Indication | Status | Phase |
---|---|---|
DBCOND0052374 (Anaplastic Oligodendroglioma (AO)) | Active Not Recruiting | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02101905 | Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma | Treatment |